Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
376-390 of 2993 results
Akers Biosciences completes clinical trial of PIFA/Chlamydia rapid assay
By MDBR Staff Writer
Health information technologies developer Akers Biosciences has completed a clinical trial in the US for rapid chlamydia test.
Diagnostics > In Vitro Diagnostics > News
ADL launches urine-based diagnostic test to detect precursor to colorectal cancer
By MDBR Staff Writer
Atlantic Diagnostic Laboratories (ADL) announced the official launch of PolypDx, a non-invasive urine-based diagnostic test for detection of adenomatous polyps, the precursor to colorectal cancer. It is estimated that there will be 134,490 new cases reported this year.
Diagnostics > In Vitro Diagnostics > News
Transplant Genomics enters collaboration with Mayo Clinic
By FBR Staff Writer
Transplant Genomics (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients.
Diagnostics > In Vitro Diagnostics > News
LabCorp launches new companion diagnostic for non-small cell lung cancer
By MDBR Staff Writer
Laboratory Corporation of America Holdings announced today the availability of a new application for the companion diagnostic associated with the use of Tarceva® for the treatment of certain patients with non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
BioLegend enters license agreement with Sanquin for peptide-MHC assay technology
By MDBR Staff Writer
BioLegend announces that it has licensed from Sanquin Blood Supply Foundation a novel technology to study antigen-specific T cells.
Diagnostics > In Vitro Diagnostics > News
Roche's procalcitonin assay gets FDA approval for sepsis management
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Roche's Elecsys BRAHMS PCT (procalcitonin) assay which will be used to aid in the management of sepsis risk.
Diagnostics > In Vitro Diagnostics > News
Rosetta Genomics receives approval from New York State for HEME FISH-based assays
By MDBR Staff Writer
Rosetta Genomics announces receipt of conditional approval from the New York State Department of Health (NYSDOH) for its multiple fluorescence in situ hybridization (FISH) tests for detection of amplifications or rearrangements of DNA in a number of hematologic cancers, such as leukemias, lymphomas and myelomas in order to form a diagnosis and/or to evaluate prognosis or remission of disease.
Diagnostics > In Vitro Diagnostics > News
AmoyDx ROS1 diagnostics test contributed to phase II clinical study of Crizotinib in lung cancer
By MDBR Staff Writer
Amoy Diagnostics announced that its AmoyDx ROS1 test successfully supported OxOnc Development LP (“OxOnc”) in the completion of a Phase II study of crizotinib (the “OxOnc Study”) in East Asian patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC).
Diagnostics > In Vitro Diagnostics > News
FDA grants EUA status for Hologic’s Aptima Zika Virus assay
By MDBR Staff Writer
Hologic has secured emergency use authorization (EUA) status from the US Food and Drug Administration (FDA) for its new Aptima Zika Virus assay.
Diagnostics > In Vitro Diagnostics > News
Great Basin Scientific introduces enhanced molecular diagnostic analyzer
By MDBR Staff Writer
Great Basin Scientific has unveiled its enhanced molecular diagnostic analyzer, which the company claims will decrease test time and increase throughput for labs.
Diagnostics > In Vitro Diagnostics > News
Alere q HIV-1/2 Detect point-of-care molecular HIV assay receives WHO prequalification
By MDBR Staff Writer
Alere, a global leader in rapid diagnostics, today announced that its Alere™ q HIV-1/2 Detect assay has been awarded World Health Organization (WHO) prequalification, making it available for public sector procurement.
Diagnostics > In Vitro Diagnostics > News
Protagen’s Multilisa BICD2 test wins CE Mark approval to diagnose systemic sclerosis
By MDBR Staff Writer
Germany-based Protagen has received CE mark approval for its Multilisa BICD2 test to diagnose systemic sclerosis (SSc).
Diagnostics > In Vitro Diagnostics > News
Avacta and Mologic partner to develop novel diagnostic tests
By MDBR Staff Writer
Avacta Group has partnered with Mologic to develop diagnostic tests against several targets of clinical interest for point of care (POC) testing.
Diagnostics > In Vitro Diagnostics > News
Great Basin begins clinical trial for stool bacterial pathogens panel
By MDBR Staff Writer
Great Basin Scientific, a molecular diagnostics company, announced today that it has initiated a clinical trial for its Stool Bacterial Pathogens Panel, a multi-plex molecular assay detecting common bacterial agents, including foodborne pathogens, present in individuals suspected of acute gastroenteritis.
Diagnostics > In Vitro Diagnostics > News
GenMark gets CE mark approval for ePlex molecular diagnostics system
By MDBR Staff Writer
GenMark Diagnostics has secured CE mark approval for its ePlex instrument system and ePlex respiratory pathogen (RP) panel.
Diagnostics > In Vitro Diagnostics > News
376-390 of 2993 results